BioSpace News Archive

The NCCN 2020 Annual Conference providing the latest updates on cancer treatment recommendations was initially postponed due to COVID-19.

Zoetis Inc. (NYSE:ZTS) will participate in the Stifel 2020 Virtual Jaws & Paws Conference on Wednesday, May 27, 2020. Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts. She is scheduled to present at 12:40 p.m. ET. Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/

SEC Order found Li and 1Globe Violated SEC Rules and Federal Securities Laws by Failing to Disclose Key Facts regarding their Holdings of Sinovac BEIJING--( BUSINESS WIRE )-- Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced that the United States Securities and Exchange Commission (“SEC”) charged activist investor, Jiaqiang “Chiang” Li and his firm 1Globe Capital LLC (

AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and cannabinoid research, announced today its oncology-focused subsidiary, Sapphire Biotech, Inc. (“Sapphire”), filed a utility patent application relating to a novel biomarker for the detection of cancer in blood serum and urine. “Sapphire’s diagnostics products have the potential to chang

Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (“Diffusion” or “the Company”), a cutting-edge biotechnology company developing new treatments for life-threatening medical conditions by improving the body’s ability to deliver oxygen to the areas where it is needed most, today announced that it has entered into definitive securities purchase agreements with certain institutional and accredited investors to purchase, in a registered direct o

Theranica today announced the appointment of two senior executives amid growing demand for the company’s prescription migraine treatment device Nerivio®.

PerkinElmer, Inc. (NYSE: PKI) supports government efforts to identify and prevent abusive practices in healthcare. PerkinElmer has received subpoenas from the government regarding investigations into third parties, and has fully cooperated with authorities and will continue to do so.

MacuHealth LLC would like to congratulate Dr Paul Bernstein and the Bernstein Laboratory for their recent publication in PNAS https://www.ncbi.nlm.nih.gov/pubmed/32409609

TB12, the health and wellness brand co-founded by six-time Super Bowl champion Tom Brady and business partner Alex Guerrero, announces today the launch of Protect, an immunity blend supplement made from clinically studied ingredients.

Bayer Fund, a philanthropic arm of life sciences company Bayer, today awarded more than $4 million in grants to 250 charities and non-profit organizations throughout the United States.